Product Information

LETROZOLE 2.5 MG TABLET is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $0.1545 per EA under NDC 51991075990. Its NADAC has been published 195 times since Mar 1, 2023.

FDA first approved this application on Jun 3, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LETROZOLE 2.5 MG TABLET

LETROZOLE
$0.1545per EA

Strength

2.5 mg/1

NDC

51991075990

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LETROZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA200161

FDA Approved

6/3/2011

TE Code

AB

On Market Since

6/4/2011

Pharmacological Classes

Aromatase Inhibitor
Aromatase Inhibitors

Price Statistics

The NADAC for LETROZOLE 2.5 MG TABLET has been published 195 times since Mar 1, 2023, and over the history we have for it it has risen 51.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1545 per EA
All-time high$0.1545 (Nov 18, 2026)
All-time low$0.1009 (Jun 21, 2023)
52-week high$0.1545
52-week low$0.1383
Median price$0.1406
Average price$0.1344
Largest weekly change+32.3% (Nov 22, 2023)
Weeks tracked195
Tracking sinceMar 1, 2023

Price History

1W

+2.9%

1M

+6.6%

3M

+2.3%

6M

+2.9%

1Y

+16.4%

3Y

+34.3%

5Y

N/A

All

+51.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LETROZOLE 2.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LETROZOLE 2.5 MG TABLET, manufactured by Breckenridge Pharmaceutical Inc., is $0.1545 per EA (NDC 51991075990), effective Nov 18, 2026.

How has the price of LETROZOLE 2.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for LETROZOLE 2.5 MG TABLET has risen 51.1%. It has been tracked across 195 weekly CMS publications since Mar 1, 2023.

What are the highest and lowest recorded NADAC prices for LETROZOLE 2.5 MG TABLET?

Since Mar 1, 2023, the NADAC for LETROZOLE 2.5 MG TABLET has ranged from a low of $0.1009 (Jun 21, 2023) to a high of $0.1545 (Nov 18, 2026), with a median of $0.1406 per EA.

Are there cheaper alternatives to LETROZOLE 2.5 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LETROZOLE 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures LETROZOLE 2.5 MG TABLET?

LETROZOLE 2.5 MG TABLET (NDC 51991075990) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.